Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Life Science Pharmaceuticals Inc.
DescriptionChimeric antibody that targets GD3 ganglioside
Molecular Target GD3 ganglioside
Mechanism of ActionBinds GD3; Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationMelanoma
Indication DetailsTreat melanoma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today